INSIGHTS ON DRUG DEVELOPMENT

• Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights

  Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.

• The Power Couple: CRISPR And Oligonucleotides

  Drug design using CRISPR depends on long guide RNA (gRNA) sequences. Find out how this match between long oligos and CRISPR works.

• Process Intensification Strategies For Smarter Biomanufacturing

  Explore how biopharma leaders are using process intensification to modernize facilities, cut costs, and increase yield with practical strategies and real-world case studies.

• 2D To 3D Transition Of Mesenchymal Stem Cell Expansion Process

  Discover how transitioning from 2D to 3D culture methods enhances the scalability, yield, and quality of Mesenchymal Stem Cells (MSCs) for therapeutic applications to address critical manufacturing challenges.

• Building Better Degraders: Targeted Protein Degradation Partners

  3/1/2024

  Learn from industry experts about the latest advances in chemical building blocks for protein degradation, including warheads, linkers, and ligands, and their role in constructing superior degrades.

• Top Challenges In Recombinant Protein Purification Process Development

  3/27/2024

  Get insights from process developers working with recombinant proteins that cannot be purified with affinity chromatography.

• Time To Intensify: Taking mAb Manufacturing To The Next Level

  8/19/2025

  Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results.

• Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions

  11/20/2025

  Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.

• Producing Therapeutic Cardiomyocytes From iPSC Stem Cells

  4/29/2024

  Experts from Albumedix and Heartseed show how they navigated challenges on the path to commercialization and successfully advanced a promising cardiomyocyte therapy to clinical trials.